The role of molecular testing in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDA) is highly aggressive and has few treatment options. To personalize therapy, it is critical to delineate molecular subtypes and understand inter- and intra-tumoral heterogeneity. Germline testing for hereditary genetic abnormalities is recommended for all patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhen, David B., Safyan, Rachael A., Konick, Eric Q., Nguyen, Ryan, Prichard, Colin C., Chiorean, E. Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184226/
https://www.ncbi.nlm.nih.gov/pubmed/37197396
http://dx.doi.org/10.1177/17562848231171456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184226/
https://www.ncbi.nlm.nih.gov/pubmed/37197396
http://dx.doi.org/10.1177/17562848231171456

Ejemplares similares